Search Results - "KAMURA, Toshiharu"

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505 by Kitagawa, Ryo, Katsumata, Noriyuki, Shibata, Taro, Kamura, Toshiharu, Kasamatsu, Takahiro, Nakanishi, Toru, Nishimura, Sadako, Ushijima, Kimio, Takano, Masashi, Satoh, Toyomi, Yoshikawa, Hiroyuki

“…In metastatic or recurrent cervical cancer, cisplatin-based chemotherapy is standard. The JCOG0505 randomized phase III trial evaluated the clinical benefits…”
Get full text

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan by Tamura, Kazuo, Aiba, Keisuke, Saeki, Toshiaki, Nakanishi, Yoichi, Kamura, Toshiharu, Baba, Hideo, Yoshida, Kazuhiro, Yamamoto, Nobuyuki, Kitagawa, Yuko, Maehara, Yoshihiko, Shimokawa, Mototsugu, Hirata, Koichi, Kitajima, Masaki

“…Background Many cancer patients suffer from the common side effect of chemotherapy-induced nausea and vomiting (CINV). Guidelines recommend a combination of…”
Get full text

Angiogenesis in cancer by Nishida, Naoyo, Yano, Hirohisa, Nishida, Takashi, Kamura, Toshiharu, Kojiro, Masamichi

“…New growth in the vascular network is important since the proliferation, as well as metastatic spread, of cancer cells depends on an adequate supply of oxygen…”
Get full text

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women by USHIJIMA, Kimio, YAHATA, Hideaki, HATAE, Masayuki, KODAMA, Shoji, SAITO, Tsuyoshi, TERAKAWA, Naoki, YAEGASHI, Nobuo, HIURA, Masamichi, SAKAMOTO, Atsuhiko, TSUDA, Hitoshi, FUKUNAGA, Masaharu, KAMURA, Toshiharu, YOSHIKAWA, Hiroyuki, KONISHI, Ikuo, YASUGI, Toshiharu, SAITO, Toshiaki, NAKANISHI, Toru, SASAKI, Hiroshi, SAJI, Fumitaka, IWASAKA, Tsuyoshi

“…To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial…”
Get full text

Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection by Satoh, Toyomi, Hatae, Masayuki, Watanabe, Yoh, Yaegashi, Nobuo, Ishiko, Osamu, Kodama, Shoji, Yamaguchi, Satoshi, Ochiai, Kazunori, Takano, Masashi, Yokota, Harushige, Kawakami, Yosuke, Nishimura, Sadako, Ogishima, Daiki, Nakagawa, Shunsuke, Kobayashi, Hiroaki, Shiozawa, Tanri, Nakanishi, Toru, Kamura, Toshiharu, Konishi, Ikuo, Yoshikawa, Hiroyuki

“…The objective of this study was to assess clinical outcomes and fertility in patients treated conservatively for unilateral stage I invasive epithelial ovarian…”
Get full text

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan by Tamura, Kazuo, Aiba, Keisuke, Saeki, Toshiaki, Nakanishi, Yoichi, Kamura, Toshiharu, Baba, Hideo, Yoshida, Kazuhiro, Yamamoto, Nobuyuki, Kitagawa, Yuko, Maehara, Yoshihiko, Shimokawa, Mototsugu, Hirata, Koichi, Kitajima, Masaki

“…Background We conducted a nationwide survey on chemotherapy-induced nausea and vomiting (CINV) in Japan and demonstrated good compliance with Japanese CINV…”
Get full text

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1 by Nishio, Shin, Kitagawa, Ryo, Shibata, Taro, Yoshikawa, Hiroyuki, Konishi, Ikuo, Ushijima, Kimio, Kamura, Toshiharu

“…Purpose The Japan Clinical Oncology Group (JCOG) trial JCOG0505 demonstrated the statistically significant non-inferiority of paclitaxel plus carboplatin (TC)…”
Get full text

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy by Kawano, Kouichiro, Tsuda, Naotake, Waki, Kayoko, Matsueda, Satoko, Hata, Yoshiro, Ushijima, Kimio, Itoh, Kyogo, Yamada, Akira, Kamura, Toshiharu

“…A feasibility study was performed to evaluate the immunological efficacy and safety of a personalized peptide vaccine (PPV) for cervical cancer patients who…”
Get full text

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer by Nishio, Shin, Ushijima, Kimio, Yamaguchi, Tomohiko, Sasajima, Yuko, Tsuda, Hitoshi, Kasamatsu, Takahiro, Kage, Masayoshi, Ono, Mayumi, Kuwano, Michihiko, Kamura, Toshiharu

“…Abstract Objective Y-box binding protein-1 (YB-1) is a member of the cold shock protein family and functions in transcription and translation. Many studies…”
Get full text

Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602 by ONDA, Takashi, Satoh, Toyomi, Saito, Toshiaki, Kasamatsu, Takahiro, Nakanishi, Toru, Takehara, Kazuhiro, Miyamoto, Kenichi, Wakabayashi, Masashi, Okamoto, Aikou, Ushijima, Kimio, Kobayashi, Hiroaki, Kawana, Kei, Yokota, Harushige, Takano, Masashi, Omatsu, Kohei, Watanabe, Yoh, Yamamoto, Kaichiro, Yaegashi, Nobuo, Kamura, Toshiharu, Yoshikawa, Hiroyuki

“…Abstract only…”
Get full text

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan by Eto, Takako, Saito, Toshiaki, Kasamatsu, Takahiro, Nakanishi, Toru, Yokota, Harushige, Satoh, Toyomi, Nogawa, Takayoshi, Yoshikawa, Hiroyuki, Kamura, Toshiharu, Konishi, Ikuo

“…Abstract Objective To evaluate clinicopathological prognostic factors and the impact of cytoreduction in patients with surgical stage IVb endometrial cancer…”
Get full text

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer by Kitagawa, Ryo, Katsumata, Noriyuki, Ando, Masashi, Shimizu, Chikako, Fujiwara, Yasuhiro, Yoshikawa, Hiroyuki, Satoh, Toyomi, Nakanishi, Toru, Ushijima, Kimio, Kamura, Toshiharu

“…Abstract Objective The aim of this prospective trial was to evaluate the efficacy and safety of the combination of paclitaxel and carboplatin (TC) in patients…”
Get full text

Chemotherapy for advanced or recurrent cervical cancer by Kamura, Toshiharu, Ushijima, Kimio

“…Abstract The primary treatment options for cervical cancer are surgery and radiation for more than a century. However, over the last 40 years chemotherapy has…”
Get full text

Overview on the 1st international workshop on gynecologic oncology by Kamura, Toshiharu

“…KCI Citation Count: 0…”
Get full text

RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer by Sanada, Sakiko, Futami, Kazunobu, Terada, Atsumu, Yonemoto, Koji, Ogasawara, Sachiko, Akiba, Jun, Yasumoto, Makiko, Sumi, Akiko, Ushijima, Kimio, Kamura, Toshiharu, Furuichi, Yasuhiro, Yano, Hirohisa

“…This study analyzed the clinicopathological correlation between ovarian cancer (OC) and RECQL1 DNA helicase to assess its therapeutic potential. Surgically…”
Get full text

Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats by Takushima, Sachiyo, Nishi, Yoshihiro, Nonoshita, Akiko, Mifune, Hiroharu, Hirata, Rumiko, Tanaka, Eiichiro, Doi, Ryosuke, Hori, Daizo, Kamura, Toshiharu, Ushijima, Kimio

“…s Aim Diminished vasodilator activity during pregnancy, which augments vascular responses to vasoconstrictors, is one reason for the onset of pre‐eclampsia and…”
Get full text

Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas by SUMI, Akiko, TERASAKI, Hiroshi, SANADA, Sakiko, UCHIDA, Masafumi, TOMIOKA, Yoshito, KAMURA, Toshiharu, YANO, Hirohisa, ABE, Toshi

“…Objectives: We retrospectively compared and quantified magnetic resonance (MR) images to distinguish major histological types of uterine sarcomas and malignant…”
Get full text

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma by Nishio, Shin, Ushijima, Kimio, Tsuda, Naotake, Takemoto, Shuji, Kawano, Kouichiro, Yamaguchi, Tomohiko, Nishida, Naoyo, Kakuma, Tatsuyuki, Tsuda, Hitoshi, Kasamatsu, Takahiro, Sasajima, Yuko, Kage, Masayoshi, Kuwano, Michihiko, Kamura, Toshiharu

“…Abstract Cap43 is a nickel- and calcium-inducible gene that plays important roles in the primary growth of malignant tumors, as well as in invasion and…”
Get full text

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study by Ushijima, Kimio, Kamura, Toshiharu, Tamura, Kazuo, Kuzuya, Kazuo, Sugiyama, Toru, Noda, Kiichiro, Ochiai, Kazunori

“…Background The aim of this phase II study was to evaluate the efficacy and toxicity of docetaxel and irinotecan combination chemotherapy in patients with…”
Get full text

A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer by Toita, Takafumi, Ohno, Tatsuya, Kaneyasu, Yuko, Uno, Takashi, Yoshimura, Ryouichi, Kodaira, Takeshi, Furutani, Kazuhisa, Kasuya, Goro, Ishikura, Satoshi, Kamura, Toshiharu, Hiraoka, Masahiro

“…Objective To develop a consensus-based guideline as well as an atlas defining pelvic nodal clinical target volumes in external beam radiotherapy for uterine…”
Get full text